The Role of PXR Genotype and Transporter Expression in the Placental Transport of Lopinavir in Mice
Open Access
- 24 October 2017
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 9 (4), 49
- https://doi.org/10.3390/pharmaceutics9040049
Abstract
Lopinavir (LPV), an antiretroviral protease inhibitor frequently prescribed in HIV-positive pregnancies, is a substrate of Abcb1 and Abcc2. As differences in placental expression of these transporters were seen in Pregnane X Receptor (PXR) −/− mice, we examined the impact of placental transporter expression and fetal PXR genotype on the fetal accumulation of LPV. PXR +/− dams bearing PXR +/+, PXR +/−, and PXR −/− fetuses were generated by mating PXR +/− female mice with PXR +/− males. On gestational day 17, dams were administered 10 mg/kg LPV (i.v.) and sacrificed 30 min post injection. Concentrations of LPV in maternal plasma and fetal tissue were measured by LC-MS/MS, and transporter expression was determined by quantitative RT-PCR. As compared to the PXR +/+ fetal units, placental expression of Abcb1a, Abcc2, and Abcg2 mRNA were two- to three-fold higher in PXR −/− fetuses (p < 0.05). Two-fold higher fetal:maternal LPV concentration ratios were also seen in the PXR +/+ as compared to the PXR −/− fetuses (p < 0.05), and this significantly correlated to the placental expression of Abcb1a (r = 0.495; p < 0.005). Individual differences in the expression of placental transporters due to genetic or environmental factors can impact fetal exposure to their substrates.Funding Information
- Canadian Institutes of Health Research (13346)
This publication has 44 references indexed in Scilit:
- Mechanisms of Reduced Maternal and Fetal Lopinavir Exposure in a Rat Model of Gestational DiabetesDrug Metabolism and Disposition, 2011
- ATP-Binding Cassette Efflux Transporters in Human PlacentaCurrent Pharmaceutical Biotechnology, 2011
- Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010Scandinavian Journal of Infectious Diseases, 2011
- Effects of cytochrome P450 3A (CYP3A) and the drug transporters P‐glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavirBritish Journal of Pharmacology, 2010
- Antiretroviral Treatment in Pregnancy: A Six-Year Perspective on Recent Trends in Prescription Patterns, Viral Load Suppression, and Pregnancy OutcomesAIDS Patient Care and STDs, 2009
- Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancyJournal of Pharmaceutical Sciences, 2009
- THE ROLE OF PREGNANE X RECEPTOR IN 2-ACETYLAMINOFLUORENE-MEDIATED INDUCTION OF DRUG TRANSPORT AND -METABOLIZING ENZYMES IN MICEDrug Metabolism and Disposition, 2005
- P-glycoprotein expression of the human placenta during pregnancyPlacenta, 2005
- INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORSDrug Metabolism and Disposition, 2003
- The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.1999